UBS Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $7.46M | Buy |
|
|||||
|
2024
Q3 | $3.32M | Buy |
|
|||||
|
2024
Q2 | $1.08M | Sell |
|
|||||
|
2024
Q1 | $1.72M | Sell |
|
|||||
|
2023
Q4 | $2.88M | Buy |
|
|||||
|
2023
Q3 | $1.5M | Sell |
|
|||||
|
2023
Q2 | $2.85M | Buy |
|
|||||
|
2023
Q1 | $1.63M | Buy |
|
|||||
|
2022
Q4 | $1.17M | Buy |
|
|||||
|
2022
Q3 | $250K | Buy |
|
|||||
|
2022
Q2 | $225K | Sell |
|
|||||
|
2022
Q1 | $722K | Sell |
|
|||||
|
2021
Q4 | $1.26M | Buy |
|
|||||
|
2021
Q3 | $258K | Buy |
|
|||||
|
2021
Q2 | $76K | Sell |
|
|||||
|
2021
Q1 | $605K | Buy |
|
|||||
|
2020
Q4 | $145K | Buy |
|
|||||
|
2020
Q3 | $43K | Sell |
|
|||||
|
2020
Q2 | $41K | Buy |
|